New TB drug regimen controls resistant disease in 9 of 10 cases
The
new open-label trial was done on 109 volunteers at three South African sites;
51% were HIV-positive and 84% had holes in the lung visible on ...
|
View article...
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.
The
new open-label trial was done on 109 volunteers at three South African sites;
51% were HIV-positive and 84% had holes in the lung visible on ...
|